Browsing: Pharmaceuticals

4 weeks ago

4 weeks ago Piramal Enterprises Q2 Revenue Shows Moderate Growth

4 weeks ago Amgen Beats Biocon to Market with Eylea Biosimilar, Impacting Biocon’s Outlook

1 month ago

1 month ago Alembic Pharma Secures USFDA Final Approval for Diltiazem Hydrochloride Extended-Release Capsules (120 mg, 180 mg, 240 mg) with $28.2M Market Potential

1 month ago Fermenta Biotech to Divest Mumbai Office Space for ₹40 Crore

Exit mobile version

Enable Notifications OK No thanks